Tram Kim Lam, Ph.D., M.P.H.
Program Director, Environmental Epidemiology Branch

Epidemiology and Genomics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
National Institutes of Health
9609 Medical Center Drive, Rm. 4E212, MSC 9763
Bethesda, MD 20892
(For express delivery, use Rockville, MD 20850)

Interest Areas

  • Cancer epidemiology, including infectious agents, lifestyle factors, genomic factors, gene-environment interactions
  • Infection-related cancers, pathogen-host co-evolution, novel infectious agents
  • Knowledge integration/meta-research to advance research by synthesizing cross-disciplinary knowledge, identifying scientific gaps, and translating epidemiologic findings
  • Understudied/under-researched populations in cancer epidemiology, health disparities


  • Ph.D. - Epidemiology
    Johns Hopkins University, Bloomberg School of Public Health
  • M.P.H. - Public Health and Epidemiology
    Johns Hopkins University, Bloomberg School of Public Health
  • B.S. - Biology
    Yale University


Dr. Tram Kim Lam is a Program Director in the Environmental Epidemiology Branch (EEB)—formerly the Modifiable Risk Factors Branch (MRFB)—of the Epidemiology and Genomics Research Program (EGRP) in NCI's Division of Cancer Control and Population Sciences (DCCPS). She oversees a research grant portfolio that focuses on modifiable factors (e.g., infectious agents, environmental exposures, genomics, and lifestyles), and the interplay between determinants of cancer and how they influence susceptibility to cancer nationally and globally. She engages in a wide range of knowledge integration/meta-research activities that collectively seek to assess the body of evidence to inform scientific priorities and research. Dr. Lam is involved in EGRP-wide efforts to understand factors that influence the practice of cancer epidemiology research and extend the reach of the discipline in the near future, such as sharing of epidemiologic data, training of the next-generation of cancer epidemiologists, translating epidemiologic findings into evidence-based practice/policy, developing evaluation metrics, and evaluating scientific initiatives.

Dr. Lam is the NCI Program Director for the transdisciplinary Breast Cancer and the Environment Research Program (BCERP) and, in collaboration with the National Institute of Environmental Health Sciences (NIEHS), provides programmatic stewardship and oversight of the project. BCERP is funded through cooperative agreements between NCI and NIEHS. Dr. Lam first joined EGRP in 2012 as a member of EGRP's Knowledge Integration Team and a Program Director in EGRP's Office of the Associate Director and former MFRB (now EEB), respectively.

Dr. Lam began her career at NCI as a Cancer Prevention Fellow and then a Cancer Research Training Fellow in the Division of Cancer Epidemiology and Genetics (DCEG). As a Fellow she designed, developed, implemented, and evaluated genomic/epidemiologic research in cancer etiology and outcomes related to genetic and lifestyle factors. During her public health career, Dr. Lam's research interests crossed disciplines and included epidemiologic studies on genetic and lifestyle factors associated with cancers, international collaboration on HIV-AIDS intervention in Southeast Asia and East Africa, and community-participatory research and health promotion to reduce cervical cancer incidence in underserved populations.


Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD. Lam et al. Respond to "driving for further evolution". Am J Epidemiol. 2015 Apr 1;181(7):463.

Lam TK, Chang CQ, Rogers SD, Khoury MJ, Schully SD. Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature. Am J Epidemiol. 2015 Apr 1;181(7):451-8.

Schully SD, Lam TK, Dotson WD, Chang CQ, Aronson N, Birkeland ML, Brewster SJ, Boccia S, Buchanan AH, Calonge N, Calzone K, Djulbegovic B, Goddard KA, Klein RD, Klein TE, Lau J, Long R, Lyman GH, Morgan RL, Palmer CG, Relling MV, Rubinstein WS, Swen JJ, Terry SF, Williams MS, Khoury MJ. Evidence synthesis and guideline development in genomic medicine: current status and future prospects. Genet Med. 2015 Jan; 17(1):63-7.

Spitz M, Lam TK, Schully SD, Khoury MJ. The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists. Am J Epidemiol. 2014 Nov 15;180(10):964-7

Lam TK, Spitz M, Schully SD, Khoury MJ. "Drivers" of translational cancer epidemiology in the 21st century: needs and opportunities. Cancer Epidemiol Biomarkers Prev. 2013;22(2):181-8.

Khoury MJ, Lam TK, Ioannidis JP, Hartge P, Spitz MR, Buring JE, Chanock SJ, Croyle RT, Goddard KA, Ginsburg GS, Herceg Z, Hiatt RA, Hoover RN, Hunter DJ, Kramer BS, Lauer MS, Meyerhardt JA, Olopade OI, Palmer JR, Sellers TA, Seminara D, Ransohoff DF, Rebbeck TR, Tourassi G, Winn DM, Zauber A, Schully SD. Transforming epidemiology for 21st century medicine and public health. Cancer Epidemiol Biomarkers Prev. 2013 Apr;22(4):508-16.

Lam TK, Rotunno M, Ryan BM, Pesatori AC, Bertazzi PA, Spitz M, Caporaso NE, Landi MT. Heme-related gene expression signatures of meat intakes in lung cancer tissues. Mol Carcinog. 2014 Jul; 53(7):548-56.

Lam TK, Schully SD, Rogers SD, Benkeser R, Reid B, Khoury MJ. Provocative questions in cancer epidemiology in a time of scientific innovation and budgetary constraints. Cancer Epidemiol Biomarkers Prev. 2013;22(4):496-500.

Lam TK, Shao S, Zhao Y, Marincola F, Pesatori A, Bertazzi PA, Caporaso NE, Wang E, Landi MT. Influence of quercetin-rich food intake on microRNA expression in lung cancer tissues. Cancer Epidemiol Biomarkers Prev. 2012;21(12):2176-84.

Koshiol J, Lam TK, Gridley G, Check D, Brown LM, Landgren O. Racial differences in chronic immune stimulatory conditions and risk of non-Hodgkin's lymphoma in veterans from the United States. J Clin Oncol. 2011;29(4):378-85.

Lam TK, Rotunno M, Lubin JH, Wacholder S, Consonni D, Pesatori AC, Bertazzi PA, Chanock SJ, Burdette L, Goldstein AM, et al. Dietary quercetin, quercetin-gene interaction, metabolic gene expression in lung tissue and lung cancer risk. Carcinogenesis. 2010;31(4):634-42.

Lam TK, Ruczinski I, Helzlsouer K, Shugart YY, Li KE, Clipp S, Strickland PT, Alberg AJ. Copy number variants of GSTM1 and GSTT1 in relation to lung cancer risk in a prospective cohort study. Ann Epidemiol. 2009;19(8):546-52.

Lam TK, Cross AJ, Consonni D, Randi G, Bagnardi V, Bertazzi PA, Caporaso NE, Sinha R, Subar AF, Landi MT. Intakes of red meat, processed meat, and meat mutagens increase lung cancer risk. Cancer Res. 2009;69(3):932-9.

Lam TK, McPhee SJ, Mock J, Wong C, Doan HT, Nguyen T, Lai KQ, Ha-Iaconis T, Luong TN. Encouraging Vietnamese-American women to obtain Pap tests through lay health worker outreach and media education. J Gen Intern Med. 2003;18(7):516-24.

Return to Top